Senicapoc and perampanel for newly diagnosed glioblastoma
Treatments studied
Part of Cancer clinical trials.
This trial tests two drugs, senicapoc and perampanel, added to standard treatment for people with newly diagnosed glioblastoma. The goal is to see if they can help slow tumor growth or improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with glioblastoma based on MRI scan within the last 4 weeks
- Planned to have surgery followed by radiation and chemotherapy (Stupp regimen)
- Able to safely wait 14 days before surgery
- Good enough health to carry out daily activities (WHO performance status 0, 1, or 2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.
This trial tests a combination of three drugs—trimipramine (an antidepressant), atezolizumab (an immunotherapy), and bevacizumab (a targeted therapy)—in people whose glioblastoma has come back after initial treatment. The goal is to see if this mix can help shrink the tumor or slow its growth.
This Phase 1/2 study tests whether “glutamate inhibitor” medications can be safely added for newly diagnosed glioblastoma, and how they affect treatment outcomes. It’s designed for adults who will also receive the standard chemo‑radiation plan with temozolomide.
This trial tests a new immunotherapy called PERCELLVAC-Sur that targets a protein (Survivin) found in glioblastoma tumors. It is given after standard radiation and chemotherapy, and the goal is to see if it helps the immune system fight the cancer more effectively.
This Phase 2 trial tests an individualized treatment approach for glioblastoma or gliosarcoma based on your tumor’s lab tests. It may help by matching therapy to tumor features and by checking how well this strategy works after surgery and planned radiation.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.